We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Laboratories Consolidate Clinical Chemistry and Immunoassay Analyzers

By LabMedica International staff writers
Posted on 09 Dec 2008
An open track-based system will enable laboratories to consolidate and automate sample processing procedures.

Laboratory automation provides more efficient sample management, improved laboratory services, and shortened turnaround times. The open track-based system offers medium to large-sized hospital and private laboratories flexibility and access to additional testing capabilities.

Olympus Life Science Europa (Hamburg, Germany) has signed an agreement with Thermo Fisher Scientific (Waltham, MA, USA) for open-track automation for clinical laboratories. The new product offering will complement existing Olympus Laboratory Automation products, including the OLA2500 peri-analytical automation system.

The agreement between the companies will allow laboratory professionals to consolidate Olympus AU-series clinical chemistry and immunoassay analyzers, including various third-party analyzers

Olympus will have the right to distribute Thermo Fisher's TC automation product line, a fully featured, track-based laboratory-automation product line, in the Americas.

Olympus will handle sales and marketing and will provide primary level service and support of the automation products.

By automating the main preanalytical steps, such as centrifugation, decapping, aliquoting and sorting, TC automation helps manage current and future workloads; it interfaces with Olympus systems plus a wide selection of third-party instruments.

Related Links:
Olympus Life Science Europa
Thermo Fisher Scientific



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit

Latest Immunology News

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
09 Dec 2008  |   Immunology

Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
09 Dec 2008  |   Immunology

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
09 Dec 2008  |   Immunology